A novel three-dimensional model system for keloid study: Organotypic multicellular scar model

Wound Repair and Regeneration

Volumn 21, Issue 1, 2013, Pages 155-165

  Lee, Won Jai ^a   Choi, Il Kyu ^b   Lee, Ju Hee ^a   Kim, Yong Oock ^a   Yun, Chae Ok ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; FIBRONECTIN; GELATINASE A; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE;

APOPTOSIS; ARTICLE; CELL VIABILITY; EX VIVO STUDY; FIBROBLAST; HUMAN; HUMAN TISSUE; KELOID; MICROENVIRONMENT; MULTICELLULAR SPHEROID; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; ELASTIN; FIBROBLASTS; HUMANS; KELOID; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; SPHEROIDS, CELLULAR; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; WOUND HEALING;

EID: 84872109442     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00869.x     Document Type: Article

References (43)

1. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP,. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006; 117: 286-300.
2. Burd A, Huang L,. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 2005; 116: 150-157.
3. Fujiwara M, Muragaki Y, Ooshima A,. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005; 153: 295-300.
4. Imaizumi R, Akasaka Y, Inomata N, Okada E, Ito K, Ishikawa Y, Maruyama Y,. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression. Histopathology 2009; 54: 722-730.
5. Niessen FB, Spauwen PH, Schalkwijk J, Kon M,. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-1458.
6. Tuan TL, Nichter LS,. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4: 19-24.
7. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV,. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87-96.
8. Myles ME, Russell JD, Trupin JS, Smith JC, Russell SB,. Keloid fibroblasts are refractory to inhibition of DNA synthesis by phorbol esters. Altered response is accompanied by reduced sensitivity to prostaglandin E2 and altered down-regulation of phorbol ester binding sites. J Biol Chem 1992; 267: 9014-9020.
9. Yang DY, Li SR, Wu JL, Chen YQ, Li G, bi S, Dai X,. Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice. Plast Reconstr Surg 2007; 119: 104-109; discussion 10-1.
10. Polo M, Kim YJ, Kucukcelebi A, Hayward PG, Ko F, Robson MC,. An in vivo model of human proliferative scar. J Surg Res 1998; 74: 187-195.
11. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA,. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 2010; 148: 3-15.
12. Friedrich J, Ebner R, Kunz-Schughart LA,. Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int J Radiat Biol 2007; 83: 849-871.
13. Abbott A,. Cell culture: biology's new dimension. Nature 2003; 424: 870-872.
14. Friedrich J, Eder W, Castaneda J, Doss M, Huber E, Ebner R, Kunz-Schughart LA,. A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. J Biomol Screen 2007; 12: 925-937.
15. Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO,. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Gene Ther 2006; 13: 1010-1020.
16. McCoy BJ, Cohen IK,. Effects of various sera on growth kinetics and collagen synthesis by keloid and normal dermal fibroblasts. Plast Reconstr Surg 1981; 67: 505-510.
17. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J,. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 2004; 50: 4008-4021.
18. Mercer NS,. Silicone gel in the treatment of keloid scars. Br J Plast Surg 1989; 42: 83-87.
19. McCoy BJ, Diegelmann RF, Cohen IK,. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 1980; 163: 216-222.
20. Escarmant P, Zimmermann S, Amar A, Ratoanina JL, Moris A, Azaloux H, Francois II, Gosserez O, Michel M, G'Baguidi R,. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 1993; 26: 245-251.
21. Bock O, Schmid-Ott G, Malewski P, Mrowietz U,. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297: 433-438.
22. Alster TS, Tanzi EL,. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003; 4: 235-243.
23. Butler PD, Ly DP, Longaker MT, Yang GP,. Use of organotypic coculture to study keloid biology. Am J Surg 2008; 195: 144-148.
24. Koch RJ, Goode RL, Simpson GT,. Serum-free keloid fibroblast cell culture: an in vitro model for the study of aberrant wound healing. Plast Reconstr Surg 1997; 99: 1094-1098.
25. Lim IJ, Phan TT, Song C, Tan WT, Longaker MT,. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 2001; 107: 797-808.
26. Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA, Kerbel RS,. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 1993; 90: 3294-3298.
27. Graham CH, Kobayashi H, Stankiewicz KS, Man S, Kapitain SJ, Kerbel RS,. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst 1994; 86: 975-982.
28. Stuschke M, Budach V, Stuben G, Streffer C, Sack H,. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system. Int J Radiat Oncol Biol Phys 1995; 32: 395-408.
29. Coolen NA, Schouten KC, Boekema BK, Middelkoop E, Ulrich MM,. Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen 2010; 18: 291-301.
30. Zeltinger J, Holbrook KA,. A model system for long-term serum-free suspension organ culture of human fetal tissues: experiments on digits and skin from multiple body regions. Cell Tissue Res 1997; 290: 51-60.
31. O'Connor KC,. Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies. Pharm Res 1999; 16: 486-493.
32. Ivascu A, Kubbies M,. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 2006; 11: 922-932.
33. Messadi DV, Le A, Berg S, Jewett A, Wen Z, Kelly P, Bertolami CN,. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999; 7: 511-517.
34. Akasaka Y, Ito K, Fujita K, Komiyama K, Ono I, Ishikawa Y, Askishima Y, Sato H, Ishii T,. Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen 2005; 13: 373-382.
35. Akasaka Y, Fujita K, Ishikawa Y, Asuwa N, Inuzuka K, Ishihara M, Ito M, Masuda T, Akishima Y, Zhang L, Ito K, Ishii T,. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 2001; 9: 501-506.
36. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A,. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 2011; 164: 83-96.
37. Roques C, Teot L,. The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 2008; 7: 137-145.
38. Ketchum LD, Smith J, Robinson DW, Masters FW,. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 1966; 38: 209-218.
39. Cruz NI, Korchin L,. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 1994; 33: 401-405.
40. Boyadjiev C, Popchristova E, Mazgalova J,. Histomorphologic changes in keloids treated with Kenacort. J Trauma 1995; 38: 299-302.
41. Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan RS, Tan EM,. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997; 37: 586-589.
42. Sadick H, Herberger A, Riedel K, Bran G, Goessler U, Hoermann K, Riedel F,. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. Int J Mol Med 2008; 22: 55-60.
43. Saed GM, Zhang W, Diamond MP,. Effect of hypoxia on stimulatory effect of TGF-beta 1 on MMP-2 and MMP-9 activities in mouse fibroblasts. J Soc Gynecol Investig 2000; 7: 348-354.